Navigation Links
Abbott to Present at Citi Investment Research Global Health Care Conference
Date:5/7/2008

ABBOTT PARK, Ill., May 7 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) will present at the Citi Investment Research Global Health Care Conference on Thursday, May 22, 2008. Thomas C. Freyman, executive vice president, finance and chief financial officer, will make a presentation on the company at 7 a.m. Central time.

A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at http://www.abbottinvestor.com. An archived edition of the presentation will be available later that day.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
2. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
3. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
4. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
5. Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
6. Abbott Hosts Conference Call for First-Quarter Earnings
7. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
8. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
9. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
10. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
11. Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... CA (PRWEB) , ... January ... ... provider of translation and localization services for life science companies, has achieved ... inspection organization, TÜV SÜD America. ISO 17100 is the globally recognized standard ...
(Date:1/23/2017)... , ... January 23, 2017 , ... ... is taught by healthcare management and evaluation leaders with decades of experience who ... pay-for-value in the United States healthcare system, there is a renewed demand for ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... applications. However, choosing the right method is paramount to success. Selecting an inappropriate ... in situations where multiple persons use the same equipment. Rare or expensive substances ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... providing high-quality general gynecological care and gynecological services for women of ... personalized care for a wide variety of reproductive services from routine health screenings ...
(Date:1/23/2017)... ... , ... “Some Infallible Characteristics of Christ”: a fascinating and entrancing novel ... the creation of published author, Rev. Dr. Robert W. Thomas, the third of seven ... for over nineteen, a pastor for over fifteen years. He is a graduate of ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... , Jan. 23, 2017 Endo International ... Trade Commission (FTC) today filed a joint motion in ... California seeking the entry of ... Order resolves all disputes between the FTC and Endo ... in connection with its Opana® ER and Lidoderm® products.  ...
(Date:1/23/2017)... Research and Markets has announced the addition of the ... their offering. ... The interventional radiology products market is expected to reach USD 8.02 ... CAGR of 4.8%. This market is segmented based on type, procedure, ... of this market are rising incidence of chronic diseases, rising geriatric ...
(Date:1/23/2017)... , Jan. 23, 2017 7D ... 510(k) clearance from the U.S. Food and Drug ... Health Canada enabling the North American commercial launch ... system for spine surgery, the 7D Surgical System.  ... cutting-edge 3D optical technologies and machine vision algorithms ...
Breaking Medicine Technology: